| Structure | Chemical Name | CAS | MF |
|
FIBRINOGEN DEGRADATION PRODUCT D HUMAN
|
|
|
|
|
FIBRINOLYTIC ENZYME 97.0+% STERILE FILTERED WHITE LYOPHILIZED (FREEZE-DRIED) POWDER
|
|
|
|
|
FIBRIN DEGRADATION PRODUCT X, HUMAN
|
|
|
|
|
FIBRINOGEN, OREGON GREEN(TM) 488 CONJUGATE
|
|
|
|
|
FIBRINOGEN, FRAGMENT D, HUMAN
|
|
|
|
FIBRINOPEPTIDE B
|
36204-23-6
|
C66H93N19O25
|
|
|
FIBRINOGEN FROM HUMAN PLASMA, ALEXA FLUOR(R) 488 CONJUGATE
|
|
|
|
|
FIBRIN DEGRADATION PRODUCT E, HUMAN
|
|
|
|
|
FIBRIN INHIBITOR, (O POLYMERIZATION)
|
|
|
|
FIBRINOGEN GAMMA-CHAIN (397-411)
|
80755-86-8
|
C62H99N23O21
|
|
FIBRINOGEN BRIDGED PEPTIDE
|
|
C92H141N35O34
|
|
|
FibrinolysinBacterial(E.C.3.4.21.7)
|
|
|
|
|
Fibrin/Fibrinogen
|
|
|
|
|
fibrinogen Genova II
|
|
|
|
|
fibrinogen Sydney I
|
|
|
|
|
fibrinogen Grand Rapids
|
|
|
|
FIBRINOPEPTIDE A, HUMAN
|
25422-31-5
|
C63H97N19O26
|
|
FIBRIN
|
9001-31-4
|
C5H11N3O2
|
|
|
fibrinogen Lille
|
|
|
|
|
fibrinogen Malmoe
|
|
|
|
|
fibrinogen-like protein
|
|
|
|
|
fibrin fragment beta (15-118)
|
|
|
|
|
fibrin self-assembly inhibitor
|
96281-16-2
|
|
|
|
fibrinopeptide Bbeta (15-42)
|
|
|
|
|
fibrinogen Logrono
|
|
|
|
|
Fibrin Tissue Adhesive
|
|
|
|
|
fibrinogen London I
|
|
|
|
|
fibrinopeptide D
|
|
|
|
|
fibril protein, Spiroplasma
|
139569-17-8
|
|
|
|
fibrinogen Bern II
|
|
|
|
|
fibrinogen Hakata
|
|
|
|
|
FIBRINOGEN,RABBITANTI-HUMAN,FROZEN/PARAFFIN(W/NBREAG.)
|
|
|
|
|
FIBRINOGEN,RABBITANTI-HUMAN
|
|
|
|
|
FIBRINOGENBBETA(BSS1-42),N-DSK,FIBRINI,CLONE:18C6,MABANTI-HUMAN,HRP
|
|
|
|
|
FIBRINOGENAALPHA(AALPHA7-16&INTACT),CLONE:FPA(19/7),MABANTI-HUMAN:ELISA/BLOT
|
|
|
|
|
FIBRINOGENAALPHA(AALPHA1-8,1-16&INTACT),CLONE:FPA(26/5),MABANTI-HUMAN:ELISA/BLOT
|
|
|
|
|
fibrinogen Bbeta (30-43)
|
|
|
|
|
fibrinogen Barcelona II
|
|
|
|
|
fibrinopeptide E
|
|
|
|
|
fibrillarin
|
|
|
|
|
FIBRINHYDROLYSATE
|
|
|
|
|
fibrinogen Canterbury
|
|
|
|
|
fibrinogen Longmont
|
|
|
|
|
fibrinogen fragment X
|
|
|
|
|
fibrinogen Kawaguchi
|
|
|
|
|
fibrinogen Madrid II
|
|
|
|
|
Fibrinogen Schwarzach
|
|
|
|
|
fibrinogen IJmuiden
|
|
|
|
|
fibrinogen Bbeta (15-42)
|
|
|
|
|
Fibrin Gel Kit, Salmon Plasma
|
|
|
|
|
fibrinogen Caracas V
|
|
|
|
|
fibrinogen fragment (Hol-DSK)
|
|
|
|
|
fibrinogen Nagoya
|
|
|
|
|
fibrinogen New York 1
|
|
|
|
fibrinogen Bbeta (1-21)
|
93334-58-8
|
C101H150N32O34
|
|
|
fibrinogen Seattle II
|
|
|
|
|
fibrinogen Milano IV
|
|
|
|
|
fibrinogen Banks peninsula
|
|
|
|
|
fibrinogen-binding protein clumping factor B
|
|
|
|
|
fibrinogen Kyoto II
|
|
|
|
|
fibrinogen Ashford
|
|
|
|
|
fibrinogen Chapel Hill II
|
|
|
|
|
FIBRINOPEPTIDEA,MABANTI-
|
|
|
|
|
FIBRINOGENBBETA(BSS1-42),N-DSK,FIBRINI,CLONE:18C6,MABANTI-HUMAN:WB/ELISA
|
|
|
|
|
FIBRINOGENGAMMA(GAMMA95-265ORDIMER),HO1-DSK,CLONE:T56,MABANTI-HUMAN:ELISA/BLOT
|
|
|
|
|
FIBRINOGEN,RABBITANTI-:WB/ID
|
|
|
|
|
fibrinogen Seattle
|
|
|
|
|
fibrinogen (gamma 95-264)
|
80801-18-9
|
|
|
|
fibrinogen peptide 6A
|
|
|
|
|
Fibrinolytic Agents
|
|
|
|
|
fibrinogen alphaC
|
|
|
|
|
fibrinogenase, Bitis arietans
|
|
|
|
|
fibrinogen Giessen I
|
|
|
|
|
fibrinogen Petoskey
|
|
|
|
|
fibrinogen-related antigen
|
|
|
|
|
fibrinogen Bremen
|
|
|
|
|
fibrinogen Aarhus
|
|
|
|
|
fibrinogen Claro
|
|
|
|
|
fibrinogen Paris
|
|
|
|
|
Fibrinogen γ-chain dodecapeptide
|
|
C50H52N8O6S
|
|
|
fibrinogen precursor peptides
|
|
|
|
|
fibrinogen Milano III
|
|
|
|
|
Fibrinogen,Oxidized(InsolubleFraction)
|
|
|
|
|
fibrinogen Haarlem
|
|
|
|
|
fibrinogen Ise
|
|
|
|
|
Fibrinogen,Oxidized(TotalFraction)
|
|
|
|
|
fibrinogen Barcelona I
|
|
|
|
|
FIBRINOGENGAMMA(GAMMA385-406&DIMERFORM),CLONE:T59,MABANTI-HUMAN:ELISA/BLOT
|
|
|
|
|
Fibrin Fibrinogen Degradation Products
|
|
|
|
|
fibrinogen Matsumoto I
|
|
|
|
|
fibrinogen-binding protein, 55-kDa
|
|
|
|
|
FIBRINUCLEASE, POWDER
|
|
|
|
|
FIBRINOGEN FACTOR 1, BABOON
|
|
|
|
|
FIBRINOGEN REFERENCE
|
|
|
|
|
fibrinogen Copenhagen II
|
|
|
|
|
fibrinogen Milano II
|
|
|
|
|
Fibrinogen, Salmon Plasma
|
|
|
|
|
Fibrinogen,Oxidized(SolubleFraction)
|
|
|
|
|
fibrinogen peptide 6D
|
|
|
|
|
fibrinogen Adelaide
|
|
|